Clinical Trial

Identification of Risk Phenotypes for Sarcopenia Using DXA WBC, Anthropometric and MA Among Young Adults

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This cross-sectional study aims to identify risk phenotypes for sarcopenia among young adults using Dual-energy X-ray Absorptiometry (DXA) for whole-body composition analysis, along with anthropometric and musculoskeletal assessments. Sarcopenia, characterized by the loss of muscle mass and strength, is a growing concern, particularly among the aging population.
Trial Details
NCT Number NCT06739850
Lead Sponsor Superior University
Conditions Sarcopenia
Enrollment 221 participants
Start Date 2024-02-28
Primary Completion 2024-05-31 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-18